What is InfoBionic.Ai?
InfoBionic.Ai is a digital health innovator dedicated to enhancing the efficiency and economics of remote patient monitoring. The company's core offering, the MoMe® Kardia device, is designed to streamline cardiac arrhythmia detection and monitoring, facilitating faster and more effective diagnosis and decision-making. Based in Massachusetts, InfoBionic.Ai is led by a team of seasoned entrepreneurs with deep expertise in healthcare, IT, medical devices, and mobile technology, particularly in remote monitoring and cardiology. Their collective experience allows them to address the complexities of traditional monitoring processes and deliver transformative solutions.
How much funding has InfoBionic.Ai raised?
InfoBionic.Ai has raised a total of $70.7M across 7 funding rounds:
Other Financing Round
$1M
Private Equity
$969K
Other Financing Round
$1.2M
Series B
$8.2M
Unspecified
$50M
Debt
$350K
Debt
$9M
Other Financing Round (2012): $1M with participation from Broadview Ventures
Private Equity (2012): $969K led by Undisclosed
Other Financing Round (2013): $1.2M supported by Cherrystone Angel Group
Series B (2015): $8.2M featuring Excel Venture Management, Zaffre Investments, and Safeguard Scientifics
Unspecified (2018): $50M backed by Blue Cross and Blue Shield of Kansas, Excel Venture Management, Zaffre Investments, Safeguard Scientifics, and Eagle Investments
Debt (2020): $350K with participation from PPP
Debt (2021): $9M led by Horizon Technology Finance
Key Investors in InfoBionic.Ai
Excel Venture Management
Excel Venture Management is a venture capital firm that invests in early-stage companies, particularly within the healthcare and technology sectors. They provide strategic guidance and capital to foster innovation and growth.
Zaffre Investments
Zaffre Investments, LLC, a subsidiary of Blue Cross Blue Shield of Massachusetts, focuses on investing in new products, services, and technologies that improve healthcare delivery. They have a particular interest in health information technology and consumer solutions.
Safeguard Scientifics
Safeguard Scientifics is a venture capital and private equity firm that provides capital and expertise to technology-driven businesses in healthcare, financial services, and digital media. They aim to fuel the growth of innovative companies.
What's next for InfoBionic.Ai?
With the infusion of major enterprise-level capital, InfoBionic.Ai is strategically positioned for significant growth and expansion. The company is expected to leverage this investment to further develop its technology, scale its operations, and broaden its market reach within the digital health sector. Future initiatives will likely focus on enhancing the capabilities of the MoMe® Kardia device and expanding its application across various patient populations and healthcare systems. The company's trajectory suggests a move towards solidifying its position as a leader in remote patient monitoring solutions, driven by a commitment to improving patient outcomes and healthcare economics.
See full InfoBionic.Ai company page
